P04-18. Comparison of HIV neutralization assays for use in vaccine research and clinical trials, phase II: Results from the NeutNet working group

G. Scarlatti, J. Alcami, V. Bongertz, E. Fenyö, A. Heath, L. Heyndrickx, H. Holmes, M. Jansson, L. Lopalco, M. Malnati, D. Montefiori, C. Moog, L. Morris, S. Osmanov, V. Polonis, M. Ramaswamy, Q. Sattentau, H. Schuitemaker, T. Wrin

Research output: Contribution to journalArticle

Original languageEnglish
Article number1742
JournalRetrovirology
Volume6
Issue numberSUPPL. 3
Publication statusPublished - Oct 22 2009

ASJC Scopus subject areas

  • Virology
  • Infectious Diseases

Cite this

Scarlatti, G., Alcami, J., Bongertz, V., Fenyö, E., Heath, A., Heyndrickx, L., Holmes, H., Jansson, M., Lopalco, L., Malnati, M., Montefiori, D., Moog, C., Morris, L., Osmanov, S., Polonis, V., Ramaswamy, M., Sattentau, Q., Schuitemaker, H., & Wrin, T. (2009). P04-18. Comparison of HIV neutralization assays for use in vaccine research and clinical trials, phase II: Results from the NeutNet working group. Retrovirology, 6(SUPPL. 3), [1742].